Adaptive Biotechnologies: Fourth Quarter Financial Highlights

Adaptive Biotechnologies Reports Fourth Quarter Financial Results

Adaptive Biotechnologies Corp., headquartered in Seattle, announced on Thursday that it recorded a net loss of $13.6 million for the fourth quarter.

During this period, the company reported a per-share loss of 9 cents.

These figures surpassed analysts’ expectations, as a consensus of four analysts polled by Zacks Investment Research had projected a loss of 19 cents per share.

The biotechnology firm generated $71.7 million in revenue for the quarter.

Looking at the full year, Adaptive Biotechnologies reduced its net loss to $59.5 million, or 39 cents per share, while total annual revenue reached $277 million.

Since the start of the year, the company’s stock price has edged up by just over 1%. By the close of trading on Thursday, shares were valued at $16.46, marking a more than twofold increase over the past year.